Alberto Bossi

8.6k total citations · 1 hit paper
106 papers, 2.6k citations indexed

About

Alberto Bossi is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Surgery. According to data from OpenAlex, Alberto Bossi has authored 106 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Pulmonary and Respiratory Medicine, 26 papers in Radiation and 18 papers in Surgery. Recurrent topics in Alberto Bossi's work include Prostate Cancer Treatment and Research (72 papers), Prostate Cancer Diagnosis and Treatment (59 papers) and Advanced Radiotherapy Techniques (26 papers). Alberto Bossi is often cited by papers focused on Prostate Cancer Treatment and Research (72 papers), Prostate Cancer Diagnosis and Treatment (59 papers) and Advanced Radiotherapy Techniques (26 papers). Alberto Bossi collaborates with scholars based in France, United States and Belgium. Alberto Bossi's co-authors include Karim Fizazi, Bernard Escudier, Pierre Blanchard, Juanita Crook, Gert De Meerleer, Valérie Fonteyne, C. Cozzarini, Thomas Wiegel, Anders Widmark and Christine Haie‐Méder and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.

In The Last Decade

Alberto Bossi

100 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer

2020 259 citations Neal D. Shore, Fred Saad et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alberto Bossi France	28	1.8k	561	556	527	487	106	2.6k
D.A. Loblaw Canada	29	2.5k 1.4×	487 0.9×	643 1.2×	877 1.7×	587 1.2×	88	3.4k
Marian Loffredo United States	27	2.7k 1.5×	300 0.5×	441 0.8×	649 1.2×	370 0.8×	82	3.0k
Jean‐Léon Lagrange France	27	1.4k 0.8×	375 0.7×	583 1.0×	573 1.1×	602 1.2×	75	2.7k
Stanley L. Liauw United States	29	2.5k 1.4×	572 1.0×	1.1k 2.0×	880 1.7×	630 1.3×	148	3.6k
Edith Canby‐Hagino United States	18	3.5k 2.0×	316 0.6×	689 1.2×	680 1.3×	449 0.9×	42	4.1k
Ignace Billiet Belgium	13	1.7k 0.9×	575 1.0×	443 0.8×	376 0.7×	283 0.6×	37	2.1k
Roland van Velthoven Belgium	21	2.3k 1.2×	302 0.5×	832 1.5×	455 0.9×	403 0.8×	82	3.0k
Filip Ameye Belgium	19	1.8k 1.0×	710 1.3×	443 0.8×	254 0.5×	288 0.6×	69	2.3k
C.A. Lawton United States	31	3.3k 1.8×	905 1.6×	494 0.9×	1.8k 3.4×	470 1.0×	83	4.4k
Valérie Fonteyne Belgium	31	3.3k 1.8×	1.3k 2.3×	790 1.4×	1.3k 2.4×	579 1.2×	132	4.2k

Countries citing papers authored by Alberto Bossi

Since Specialization

Citations

This map shows the geographic impact of Alberto Bossi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alberto Bossi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alberto Bossi more than expected).

Fields of papers citing papers by Alberto Bossi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alberto Bossi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alberto Bossi. The network helps show where Alberto Bossi may publish in the future.

Co-authorship network of co-authors of Alberto Bossi

This figure shows the co-authorship network connecting the top 25 collaborators of Alberto Bossi. A scholar is included among the top collaborators of Alberto Bossi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alberto Bossi. Alberto Bossi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Spratt, Daniel E., Daniel J. George, Neal D. Shore, et al.. (2024). Efficacy and Safety of Radiotherapy Plus Relugolix in Men With Localized or Advanced Prostate Cancer. JAMA Oncology. 10(5). 594–594. 4 indexed citations

Bossi, Alberto, Stéphanie Foulon, Xavier Maldonado, et al.. (2024). Efficacy and safety of prostate radiotherapy in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design. The Lancet. 404(10467). 2065–2076. 21 indexed citations

George, Daniel J., Fred Saad, Michael S. Cookson, et al.. (2023). Impact of Concomitant Prostate Cancer Medications on Efficacy and Safety of Relugolix Versus Leuprolide in Men With Advanced Prostate Cancer. Clinical Genitourinary Cancer. 21(3). 383–392.e2. 6 indexed citations

Bossi, Alberto, et al.. (2022). High-risk Locally Advanced Prostate Cancer: Multimodal Treatment Is the Key. European Urology Open Science. 38. 14–16. 3 indexed citations

Fizazi, Karim, Joan Carles, Guilhem Roubaud, et al.. (2021). LBA5 A phase III trial with a 2x2 factorial design in men with de novo metastatic castration-sensitive prostate cancer: Overall survival with abiraterone acetate plus prednisone in PEACE-1. Annals of Oncology. 32. S1299–S1299. 31 indexed citations

Ung, Mony, et al.. (2021). Impact dosimétrique de la pose d’un espaceur rectal dans le traitement de cancer de la prostate localisé par irradiation en conditions stéréotaxiques. Cancer/Radiothérapie. 25(3). 237–241. 3 indexed citations

Bossi, Alberto, Neal D. Shore, Ronald Tutrone, et al.. (2021). 622P Geographical assessment of efficacy and safety of relugolix: A subgroup analysis from the randomized, phase III HERO study vs leuprolide (LEU) in men with advanced prostate cancer (APC). Annals of Oncology. 32. S660–S660.

Chargari, Cyrus, Éric Deutsch, Pierre Blanchard, et al.. (2019). Brachytherapy: An overview for clinicians. CA A Cancer Journal for Clinicians. 69(5). 386–401. 191 indexed citations

Crevoisier, R. de, Mohamed Amine Bayar, P. Pommier, et al.. (2018). Daily Versus Weekly Prostate Cancer Image Guided Radiation Therapy: Phase 3 Multicenter Randomized Trial. International Journal of Radiation Oncology*Biology*Physics. 102(5). 1420–1429. 77 indexed citations

10.

Gómez‐Iturriaga, Alfonso, F. Casquero, José Ignacio Pijoán, et al.. (2018). Pretreatment Multiparametric Magnetic Resonance Imaging Findings Are More Accurate Independent Predictors of Outcome Than Clinical Variables in Localized Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 101(5). 1172–1178. 6 indexed citations

11.

Pieters, Bradley R., Elzbieta van der Steen-Banasik, Geert A.H.J. Smits, et al.. (2017). GEC-ESTRO/ACROP recommendations for performing bladder-sparing treatment with brachytherapy for muscle-invasive bladder carcinoma. Radiotherapy and Oncology. 122(3). 340–346. 15 indexed citations

12.

Obéric, Lucie, Christophe Massard, Gwénaël Le Teuff, et al.. (2016). Predicting and preventing thromboembolic events in patients receiving cisplatin-based chemotherapy for germ cell tumours. European Journal of Cancer. 69. 151–157. 29 indexed citations

13.

Wolff, Robert, Steve Ryder, Alberto Bossi, et al.. (2015). A systematic review of randomised controlled trials of radiotherapy for localised prostate cancer. European Journal of Cancer. 51(16). 2345–2367. 63 indexed citations

14.

Meerleer, Gert De, Vincent Khoo, Bernard Escudier, et al.. (2014). Radiotherapy for renal-cell carcinoma. The Lancet Oncology. 15(4). e170–e177. 206 indexed citations

15.

Nickers, P., Pierre Blanchard, Jean‐Michel Hannoun‐Lévi, et al.. (2013). Curiethérapie prostatique de haut débit de dose. Cancer/Radiothérapie. 17(2). 118–124. 7 indexed citations

16.

Denis, Louis, et al.. (2012). PCA: Prostate Cancer, Patient‐Centred Approach or both?. British Journal of Urology. 110(1). 16–22. 12 indexed citations

17.

Pommier, P., Magali Morelle, Lionel Perrier, et al.. (2012). Évaluation économique prospective de la radiothérapie guidée par l’image des cancers de la prostate dans le cadre du programme national de soutien aux thérapeutiques innovantes et coûteuses. Cancer/Radiothérapie. 16(5-6). 444–451. 13 indexed citations

18.

Thuret, Rodolphe, Christophe Massard, Marine Gross‐Goupil, et al.. (2008). The postchemotherapy PSA surge syndrome. Annals of Oncology. 19(7). 1308–1311. 47 indexed citations

19.

Bossi, Alberto, Amr Mousa, Jan Verstraete, & Erik Van Limbergen. (2007). Target Volume Delineation for Postoperative Radiotherapy of Soft Tissue Sarcoma: Impact of Digital Fusion of Preoperative Images With Postoperative Images. International Journal of Radiation Oncology*Biology*Physics. 69(3). S747–S747. 1 indexed citations

20.

Maffezzini, Massimo, Alberto Bossi, & Laurence Collette. (2006). Implications of Prostate-Specific Antigen Doubling Time as Indicator of Failure after Surgery or Radiation Therapy for Prostate Cancer. European Urology. 51(3). 605–613. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact